Annelisa Cornel

MetaboCAR

MetaboCAR develops CAR-T immunotherapies that target metabolic stress molecules shared across multiple childhood cancers. By turning metabolic vulnerabilities into actionable immune targets, the approach seeks to overcome limitations of antigen-specific CAR-T strategies. The project aims to create broadly applicable immunotherapies for pediatric cancers with significant unmet clinical need.